DK2513107T3 - Heteroaromatiske phenylimidazol-derivater som pde10a-enzyminhibitorer - Google Patents

Heteroaromatiske phenylimidazol-derivater som pde10a-enzyminhibitorer

Info

Publication number
DK2513107T3
DK2513107T3 DK10798255.5T DK10798255T DK2513107T3 DK 2513107 T3 DK2513107 T3 DK 2513107T3 DK 10798255 T DK10798255 T DK 10798255T DK 2513107 T3 DK2513107 T3 DK 2513107T3
Authority
DK
Denmark
Prior art keywords
enzyminhibitors
pde10a
phenylimidazole derivatives
heteroaromatic
heteroaromatic phenylimidazole
Prior art date
Application number
DK10798255.5T
Other languages
Danish (da)
English (en)
Inventor
Jacob Nielsen
Jan Kehler
John Paul Kilburn
Morten Langgård
Ask Püschl
Mauro Marigo
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of DK2513107T3 publication Critical patent/DK2513107T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Valve Device For Special Equipments (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK10798255.5T 2009-12-17 2010-12-15 Heteroaromatiske phenylimidazol-derivater som pde10a-enzyminhibitorer DK2513107T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28731509P 2009-12-17 2009-12-17
DKPA200901339 2009-12-17
PCT/DK2010/050341 WO2011072694A1 (en) 2009-12-17 2010-12-15 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors

Publications (1)

Publication Number Publication Date
DK2513107T3 true DK2513107T3 (da) 2014-10-13

Family

ID=44246808

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10798255.5T DK2513107T3 (da) 2009-12-17 2010-12-15 Heteroaromatiske phenylimidazol-derivater som pde10a-enzyminhibitorer

Country Status (36)

Country Link
US (2) US9096589B2 (ja)
EP (1) EP2513107B1 (ja)
JP (1) JP5901535B2 (ja)
KR (1) KR101803984B1 (ja)
CN (1) CN102741250B (ja)
AR (1) AR079495A1 (ja)
AU (1) AU2010333435B2 (ja)
BR (1) BR112012017205A2 (ja)
CA (1) CA2783726A1 (ja)
CO (1) CO6612245A2 (ja)
CR (1) CR20120319A (ja)
CY (1) CY1115843T1 (ja)
DK (1) DK2513107T3 (ja)
DO (1) DOP2012000165A (ja)
EA (1) EA023663B1 (ja)
ES (1) ES2514647T3 (ja)
GE (1) GEP20156241B (ja)
GT (1) GT201200171A (ja)
HK (1) HK1177208A1 (ja)
HR (1) HRP20140898T1 (ja)
IL (1) IL220327A (ja)
MA (1) MA33922B1 (ja)
MX (1) MX2012006969A (ja)
MY (1) MY158197A (ja)
NZ (1) NZ600260A (ja)
PL (1) PL2513107T3 (ja)
PT (1) PT2513107E (ja)
RS (1) RS53579B1 (ja)
SG (1) SG181674A1 (ja)
SI (1) SI2513107T1 (ja)
SM (1) SMT201400158B (ja)
TN (1) TN2012000271A1 (ja)
TW (1) TWI485151B (ja)
UA (1) UA108487C2 (ja)
WO (1) WO2011072694A1 (ja)
ZA (1) ZA201204419B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI485151B (zh) 2009-12-17 2015-05-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
TWI487705B (zh) 2009-12-17 2015-06-11 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物
TWI481607B (zh) 2009-12-17 2015-04-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物
JP5911476B2 (ja) * 2010-05-26 2016-04-27 スノビオン プハルマセウトイカルス インコーポレイテッド ヘテロアリール化合物及びその使用方法
JO3089B1 (ar) * 2010-11-19 2017-03-15 H Lundbeck As مشتقات ايميدازول كمثبطات لانزيمات pde10a
US8552045B2 (en) 2010-11-19 2013-10-08 H. Lundbeck A/S Tricyclic imidazole compounds as PDE10 inhibitors
CN107141309A (zh) 2011-01-11 2017-09-08 桑诺维恩药品公司 杂芳基化合物及其使用方法
AU2012219316A1 (en) 2011-02-18 2013-10-03 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
US9938269B2 (en) * 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
EA201490599A1 (ru) * 2011-09-19 2014-07-30 Ф.Хоффманн-Ля Рош Аг Соединения триазолопиридина в качестве ингибиторов фосфодиэстеразы pde10a
WO2013050527A1 (en) 2011-10-05 2013-04-11 H. Lundbeck A/S Quinazoline derivatives as pde10a enzyme inhibitors
AR089361A1 (es) 2011-12-21 2014-08-20 Lundbeck & Co As H Derivados de quinolina como inhibidores de la enzima pde10a
IN2015DN00345A (ja) 2012-06-19 2015-06-12 Sunovion Pharmaceuticals Inc
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9790203B2 (en) * 2012-11-26 2017-10-17 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307865D0 (en) 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US5571775A (en) 1994-07-11 1996-11-05 Dowelanco N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
IL149106A0 (en) 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
FR2824065A1 (fr) 2001-04-26 2002-10-31 Neuro3D Composes inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
DE60324449D1 (de) 2002-10-30 2008-12-11 Via Pharmaceuticals Inc Inhibitoren der phosphodiesterase der zyklischen n, und deren verwendung in therapie
ATE438398T1 (de) 2003-06-30 2009-08-15 Nycomed Gmbh Pyrrolo-dihydroisochinolin-derivate als pde10- inhibitoren
MXPA05013553A (es) 2003-06-30 2006-03-09 Altana Pharma Ag Pirrolodihidroisoquinolinas como inhibidores de pde10.
US20070032404A1 (en) 2003-07-31 2007-02-08 Bayer Pharmaceuticals Corporation Methods for treating diabetes and related disorders using pde10a inhibitors
CA2556413A1 (en) 2004-02-18 2005-09-09 Pfizer Products Inc. Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
FR2870539B1 (fr) 2004-05-19 2006-08-04 Greenpharma Sa Sa Nouvelles methodes et medicaments
EP1755611A1 (en) 2004-06-07 2007-02-28 Pfizer Products Inc. Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
MX2007002592A (es) 2004-09-03 2007-10-10 Memory Pharm Corp Derivados 4,6 -dialcoxi - cinnolina 4 - sustituidos como inhibidores de la fosfodiesterasa 10 para el tratamiento de sindromes psiquiatricos o neurologicos.
NL2000397C2 (nl) * 2006-01-05 2007-10-30 Pfizer Prod Inc Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
US20080090834A1 (en) * 2006-07-06 2008-04-17 Pfizer Inc Selective azole pde10a inhibitor compounds
CN101495476A (zh) * 2006-07-10 2009-07-29 H.隆德贝克有限公司 6,7-二烷氧基喹唑啉、6,7-二烷氧基酞嗪和6,7-二烷氧基异喹啉的(3-芳基-哌嗪-1-基)、(2-芳基-吗啉-4-基)和(2-芳基-硫代吗啉-4-基)衍生物
AU2008276521B2 (en) 2007-07-17 2011-11-03 Amgen Inc. Heterocyclic modulators of PKB
US8133897B2 (en) 2008-06-20 2012-03-13 H. Lundbeck A/S Phenylimidazole derivatives as PDE10A enzyme inhibitors
UA102693C2 (ru) 2008-06-20 2013-08-12 Х. Луннбек А/С Производные фенилимидазола как ингибиторы фермента pde10a
TWI501965B (zh) * 2008-06-20 2015-10-01 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
TWI485151B (zh) 2009-12-17 2015-05-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
TW201200516A (en) 2009-12-17 2012-01-01 Lundbeck & Co As H Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors
TWI487705B (zh) 2009-12-17 2015-06-11 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物
TWI481607B (zh) 2009-12-17 2015-04-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物

Also Published As

Publication number Publication date
ES2514647T3 (es) 2014-10-28
AR079495A1 (es) 2012-02-01
US9669029B2 (en) 2017-06-06
BR112012017205A2 (pt) 2018-08-14
US20120309714A1 (en) 2012-12-06
WO2011072694A1 (en) 2011-06-23
KR101803984B1 (ko) 2017-12-01
IL220327A (en) 2014-12-31
TWI485151B (zh) 2015-05-21
CR20120319A (es) 2012-08-16
CO6612245A2 (es) 2013-02-01
MY158197A (en) 2016-09-15
RS53579B1 (en) 2015-02-27
MX2012006969A (es) 2012-07-17
SMT201400158B (it) 2015-01-15
TN2012000271A1 (en) 2013-12-12
CN102741250B (zh) 2015-10-14
AU2010333435A1 (en) 2012-06-21
CA2783726A1 (en) 2011-06-23
JP5901535B2 (ja) 2016-04-13
AU2010333435B2 (en) 2016-09-08
NZ600260A (en) 2014-08-29
EA023663B1 (ru) 2016-06-30
ZA201204419B (en) 2013-08-28
EA201290516A1 (ru) 2013-01-30
EP2513107A1 (en) 2012-10-24
HRP20140898T1 (hr) 2014-11-07
KR20120112460A (ko) 2012-10-11
CY1115843T1 (el) 2017-01-25
PL2513107T3 (pl) 2014-12-31
GT201200171A (es) 2015-01-16
US20150290191A1 (en) 2015-10-15
JP2013514284A (ja) 2013-04-25
SG181674A1 (en) 2012-07-30
EP2513107B1 (en) 2014-07-30
SI2513107T1 (sl) 2014-11-28
US9096589B2 (en) 2015-08-04
UA108487C2 (en) 2015-05-12
TW201200515A (en) 2012-01-01
IL220327A0 (en) 2012-08-30
HK1177208A1 (en) 2013-08-16
MA33922B1 (fr) 2013-01-02
PT2513107E (pt) 2014-10-22
CN102741250A (zh) 2012-10-17
GEP20156241B (en) 2015-02-10
DOP2012000165A (es) 2012-12-15

Similar Documents

Publication Publication Date Title
DK2513107T3 (da) Heteroaromatiske phenylimidazol-derivater som pde10a-enzyminhibitorer
DK2513106T3 (da) Heteroaromatiske aryltriazol-derivater som pde10a-enzyminhibitorer
DK2590974T3 (da) Tetrahydropyridopyrimidinderivater
DK2308877T3 (da) Imidazopyridin-2-on-derivater
ECSP12011999A (es) Derivados benzamida sustituidos
DK2397480T3 (da) Diazepindionderivat
DK2513105T3 (da) 2-arylimidazolderivater som pde10a-enzyminhibitorer
DK2275414T3 (da) Cyclopentylacrylamidderivat
BRPI1009465A2 (pt) Formulação
DK3070091T3 (da) Benzodioxolderivater som phosphodiesterasehæmmere
DK2387580T3 (da) Deoxyactagardinderivater
FR2935592B1 (fr) Poudrier
SMT201400080B (it) Derivati di pirazinoossazepina
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate
SMT201600405B (it) Derivati di arilalchilamminocarbossammide fluorurati
BR112012028007A2 (pt) composição aquosa
SMT201500067B (it) Derivati di acilbenzene
TH104960B (th) อนุพันธ์ซับสทิทิวเต็ดอะริลลาไมด์ออกซาเซพิโนไพริมิโดน
BR112013013207A2 (pt) derivados de pirimidina
TH104957B (th) อนุพันธ์พาทาลาซิโนน
TH125478B (th) สารอนุพันธ์ 3-ไฮดรอกซีไพริด-4-โอน
UA18828S (uk) Шафа
UA20036S (uk) Шафа
TH107642B (th) ตู้เสื้อผ้า
TH106204B (th) ตู้เสื้อผ้า